| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORP | Director | Common Stock | 29,865 | $290,287 | $9.72 | 11 Jun 2025 | Direct |
| RECURSION PHARMACEUTICALS, INC. | Director | Class A Common Stock | 47,557 | $214,482 | $4.51 | 18 Jun 2025 | Direct |
| DYNAVAX TECHNOLOGIES CORP | Director | Stock Option (Right to Buy) | 28,500 | 11 Jun 2025 | Direct | ||
| RECURSION PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 22,016 | 18 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | 18 Jun 2025 | 2 | $0 | 4 | Director | 23 Jun 2025, 17:22 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 11 Jun 2025 | 2 | $0 | 4 | Director | 13 Jun 2025, 17:44 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 17 Mar 2025 | 2 | $0 | 4 | Director | 19 Mar 2025, 16:27 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 15 Mar 2025 | 0 | $0 | 3 | Director | 19 Mar 2025, 16:25 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 23 May 2024 | 2 | $0 | 4 | Director | 28 May 2024, 20:19 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 26 May 2023 | 2 | $0 | 4 | Director | 31 May 2023, 17:34 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 26 May 2022 | 2 | $0 | 4 | Director | 27 May 2022, 17:01 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 10 Dec 2021 | 2 | $0 | 4 | Director | 14 Dec 2021, 18:23 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 10 Dec 2021 | 0 | $0 | 3 | Director | 14 Dec 2021, 16:04 |